Sofgen Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SOFGEN PHARMS, and what generic and branded alternatives to SOFGEN PHARMS drugs are available?
SOFGEN PHARMS has four approved drugs.
Drugs and US Patents for Sofgen Pharms
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sofgen Pharms | NIMODIPINE | nimodipine | CAPSULE;ORAL | 201832-001 | Jul 24, 2015 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Sofgen Pharms | OMEGA-3-ACID ETHYL ESTERS | omega-3-acid ethyl esters | CAPSULE;ORAL | 211355-001 | Jul 10, 2019 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Sofgen Pharms | PROGESTERONE | progesterone | CAPSULE;ORAL | 200456-001 | Sep 28, 2012 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.